Urothelial Carcinoma

临床试验

计划入组 1,000 人 · 首次发布于 2021 年 7 月 21 日

终止

NCT04960956

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

计划入组 13 人 · 首次发布于 2021 年 7 月 14 日

Unknown

NCT01378052

DNA Methylation and Urothelial Carcinoma

计划入组 200 人 · 首次发布于 2011 年 6 月 22 日

药物

查看全部 101 →

Biotech

Approved

Avelumab(Bavencio)

相关疾病：Advanced Renal Cell Carcinoma, Metastatic Urothelial Cancer，另有 2 项

Small Molecule

Approved

Erdafitinib(Balversa)

相关疾病：Locally Advanced or Metastatic Urothelial Carcinoma (UC)

C₂₅H₃₀N₆O₂

Biotech

Approved

Atezolizumab(Tecentriq)

相关疾病：Metastatic Alveolar Soft Part Sarcoma, Metastatic Hepatocellular Carcinoma，另有 11 项

Rx

机构

Senti Biosciences, Inc.

United States

资讯

查看全部 1963 →

2年前

Mabwell's 9MW2821 and Astellas' Padcev Advance in China for Urothelial Cancer Treatment

24天前

GI Innovation's GI-101A Wins FDA Fast Track Designation for Metastatic Urothelial Carcinoma

去年

临床试验

Bio Clinical Collection of Urothelial Carcinoma

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

DNA Methylation and Urothelial Carcinoma

药物

Avelumab(Bavencio)

Erdafitinib(Balversa)

Atezolizumab(Tecentriq)

机构

Senti Biosciences, Inc.

资讯

Mabwell's 9MW2821 and Astellas' Padcev Advance in China for Urothelial Cancer Treatment

GI Innovation's GI-101A Wins FDA Fast Track Designation for Metastatic Urothelial Carcinoma

Optimizing Frontline Treatment Strategies in Urothelial Carcinoma